Clinical Trial Update: To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and long-term safety of Ozanimod in Japanese patients with moderately to severely active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Celgene | Conditions: Colitis, Ulcerative | Phase 3 | Status: COMPLETED